Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

Por Kyle, RA, Rajkumar, SV
Publicado em 2008

Treatment patterns and outcomes in elderly patients with multiple myeloma

Por Bang, S-M, Kyle, RA, Rajkumar, SV, Kumar, S
Publicado em 2012

Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients

Por Roeker, LE, Larson, DR, Kyle, RA, Kumar, S, Dispenzieri, A, Rajkumar, SV
Publicado em 2013

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

Por Larsen, JT, Kumar, SK, Dispenzieri, A, Kyle, RA, Katzmann, JA, Rajkumar, SV
Publicado em 2012

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma

Por Rajkumar, SV, Gupta, V, Fonseca, R, Dispenzieri, A, Gonsalves, WI, Larson, D, Ketterling, RP, Lust, JA, Kyle, RA, Kumar, SK
Publicado em 2013

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system

Por Snozek, CLH, Katzmann, JA, Kyle, RA, Dispenzieri, A, Larson, DR, Therneau, TM, Melton, LJ, Kumar, S, Greipp, PR, Clark, RJ, Rajkumar, SV
Publicado em 2008

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

Por Short, K Detweiler, Rajkumar, SV, Larson, D, Buadi, F, Hayman, S, Dispenzieri, A, Gertz, M, Kumar, S, Mikhael, J, Roy, V, Kyle, RA, Lacy, MQ
Publicado em 2011

Clinical and biological significance of RAS mutations in multiple myeloma

Por Chng, WJ, Gonzalez-Paz, N, Price-Troska, T, Jacobus, S, Rajkumar, SV, Oken, MM, Kyle, RA, Henderson, KJ, Van Wier, S, Greipp, P, Van Ness, B, Fonseca, R
Publicado em 2008

Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS

Por Katzmann, JA, Clark, R, Kyle, RA, Larson, DR, Therneau, TM, Melton, LJ, Benson, JT, Colby, CL, Dispenzieri, A, Landgren, O, Kumar, S, Bradwell, AR, Cerhan, JR, Rajkumar, SV
Publicado em 2012

Genetic polymorphisms of EPHX1, Gsk3β, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma

Por Durie, BGM, Van Ness, B, Ramos, C, Stephens, O, Haznadar, M, Hoering, A, Haessler, J, Katz, MS, Mundy, GR, Kyle, RA, Morgan, GJ, Crowley, J, Barlogie, B, Shaughnessy, J
Publicado em 2009

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents

Por Majithia, N, Rajkumar, SV, Lacy, MQ, Buadi, FK, Dispenzieri, A, Gertz, MA, Hayman, SR, Dingli, D, Kapoor, P, Hwa, L, Lust, JA, Russell, SJ, Go, RS, Kyle, RA, Kumar, SK
Publicado no Leukemia (2016)

RELATIONSHIP BETWEEN ELEVATED IMMUNOGLOBULIN FREE LIGHT CHAIN AND THE PRESENCE OF IgH TRANSLOCATIONS IN MULTIPLE MYELOMA

Por Kumar, S., Zhang, L., Dispenzieri, A., Van Wier, S., Katzmann, J.A., Snyder, M., Blood, E., DeGoey, R., Henderson, K., Kyle, R.A., Bradwell, A.R., Greipp, P.R., Rajkumar, S.V., Fonseca, R
Publicado em 2010

Genetic aberrations and survival in plasma cell leukemia

Por Tiedemann, RE, Gonzalez-Paz, N, Kyle, RA, Santana-Davila, R, Price-Troska, T, Van Wier, SA, Chng, WJ, Ketterling, RP, Gertz, MA, Henderson, K, Greipp, PR, Dispenzieri, A, Lacy, MQ, Rajkumar, SV, Bergsagel, PL, Stewart, AK, Fonseca, R
Publicado em 2008

Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

Por Hari, PN, Majhail, NS, Zhang, M-J, Hassebroek, A, Siddiqui, F, Ballen, K, Bashey, A, Bird, J, Freytes, CO, Gibson, J, Hale, G, Holmberg, L, Kamble, R, Kyle, RA, Lazarus, HM, LeMaistre, CF, Loberiza, F, Maiolino, A, McCarthy, PL, Milone, G, Omondi, N, Reece, DE, Seftel, M, Trigg, M, Vesole, D, Weiss, B, Wiernik, P, Lee, SJ, Rizzo, JD, Mehta, P
Publicado em 2009